Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Novo nordisk a::S save search
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
Published: 2023-02-08 (Crawled : 11:00) - globenewswire.com
NVO | $139.58 -0.01% 0.19% 1.9K
|
Health Technology
|
| O: 1.71%
H: 0.09%
C: -0.85%
Novo Nordisk A/S - share repurchase programme
Published: 2023-02-07 (Crawled : 20:00) - globenewswire.com
NVO | $139.58 -0.01% 0.19% 1.9K
|
Health Technology
|
| O: 1.71%
H: 0.09%
C: -0.85%
repurchase
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
Published: 2023-02-07 (Crawled : 13:00) - globenewswire.com
NVO | $139.58 -0.01% 0.19% 1.9K
|
Health Technology
|
| O: 0.58%
H: 0.0%
C: 0.0%
Innate Pharma to Participate in Upcoming Investor Conferences - February 07, 2023
Published: 2023-02-07 (Crawled : 10:00) - biospace.com/
NVO | $139.58 -0.01% 0.19% 1.9K
|
Health Technology
|
| O: 0.58%
H: 0.0%
C: 0.0%
SNY | $47.71 1.58% 1.57% 0
|
Health Technology
|
| O: 1.64%
H: 0.0%
C: 0.0%
pharma
Smart Insulin Pens Market Size to Reach USD 302.1 Million in 2030 | Emergen Research
Published: 2023-02-06 (Crawled : 18:00) - prnewswire.com
NVO | $139.58 -0.01% 0.19% 1.9K
|
Health Technology
|
| O: 1.43%
H: 0.0%
C: 0.0%
MDT F | $86.16 -0.49% 0.0% 210
|
Health Technology
|
| O: -0.02%
H: 0.08%
C: -1.83%
LLY M | $340.73 0.31% 0.5% 970
|
Health Technology
|
| O: 2.75%
H: 0.42%
C: -1.26%
SNY | $47.71 1.58% 1.57% 0
|
Health Technology
|
| O: -0.84%
H: 0.0%
C: 0.0%
research smart insulin market
Trading in Novo Nordisk shares by board members, executives and associated persons
Published: 2023-02-03 (Crawled : 16:00) - globenewswire.com
NVO | $139.58 -0.01% 0.19% 1.9K
|
Health Technology
|
| O: 2.52%
H: 0.0%
C: 0.0%
Trading in Novo Nordisk shares by board members, executives and associated persons
Published: 2023-02-02 (Crawled : 19:00) - globenewswire.com
NVO | $139.58 -0.01% 0.19% 1.9K
|
Health Technology
|
| O: 2.52%
H: 0.0%
C: 0.0%
Novo Nordisk's sales increased by 26% in Danish kroner and by 16% at constant exchange rates to DKK 177.0 billion in 2022
Published: 2023-02-01 (Crawled : 07:00) - globenewswire.com
NVO | $139.58 -0.01% 0.19% 1.9K
|
Health Technology
|
| O: 1.5%
H: 0.26%
C: -0.52%
sales
Novo Nordisk A/S - share repurchase programme
Published: 2023-01-31 (Crawled : 12:20) - globenewswire.com
NVO | $139.58 -0.01% 0.19% 1.9K
|
Health Technology
|
| O: -2.09%
H: 0.0%
C: 0.0%
repurchase
Innate Pharma Announces HSR Clearance Regarding Expansion of Its Collaboration With Sanofi on NK Cell Engagers
Published: 2023-01-25 (Crawled : 07:00) - biospace.com/
NVO | $139.58 -0.01% 0.19% 1.9K
|
Health Technology
|
| O: -1.93%
H: 0.0%
C: 0.0%
SNY | $47.71 1.58% 1.57% 0
|
Health Technology
|
| O: 0.39%
H: 0.0%
C: 0.0%
IPHA | $3.4 -0.59% -0.59% 29K
|
Health Technology
|
| O: -1.38%
H: 0.0%
C: 0.0%
clearance expansion pharma collaboration sanofi
Novo Nordisk A/S – Share repurchase programme
Published: 2023-01-23 (Crawled : 12:00) - globenewswire.com
NVO | $139.58 -0.01% 0.19% 1.9K
|
Health Technology
|
| O: 0.63%
H: 0.16%
C: -0.14%
repurchase
Global (AI) Artificial Intelligence in Precision Medicine Market Size Will Grow Over USD 26.24 Billion By 2032, at 35.5% CAGR: Report by Polaris Market Research
Published: 2023-01-20 (Crawled : 13:00) - prnewswire.com
NVO | $139.58 -0.01% 0.19% 1.9K
|
Health Technology
|
| O: 0.31%
H: 0.0%
C: 0.0%
SNY | $47.71 1.58% 1.57% 0
|
Health Technology
|
| O: -0.41%
H: 0.0%
C: 0.0%
NVDA | $222.05 0.14% 1.61% 400K
|
Electronic Technology
|
| O: -0.15%
H: 0.0%
C: 0.0%
MSFT | $266.73 -0.31% 1.43% 390K
|
Technology Services
|
| O: -0.07%
H: 0.0%
C: 0.0%
INTC M | $28.24 -2.79% -1.82% 220K
|
Electronic Technology
|
| O: -0.73%
H: 0.0%
C: 0.0%
GOOGL G | $99.37 -7.68% -8.42% 1.1M
|
Technology Services
|
| O: 4.67%
H: 0.0%
C: 0.0%
GOOG | $100.0 -7.44% -8.15% 740K
|
Technology Services
|
| O: 4.49%
H: 0.0%
C: 0.0%
research global report market
Global Bleeding Disorders Treatment Market Report 2022: Industry Trends, Share, Size, Growth, Opportunities and Forecasts 2021-2027
Published: 2023-01-19 (Crawled : 21:00) - prnewswire.com
TAK | $16.12 1.26% 0.0% 76
|
Health Technology
|
| O: 0.28%
H: 0.0%
C: 0.0%
NVO | $139.58 -0.01% 0.19% 1.9K
|
Health Technology
|
| O: 0.31%
H: 0.0%
C: 0.0%
JNJ | $163.61 0.13% 0.29% 3.8K
|
Health Technology
|
| O: 0.43%
H: 0.0%
C: 0.0%
SNY | $47.71 1.58% 1.57% 0
|
Health Technology
|
| O: -0.41%
H: 0.0%
C: 0.0%
treatment bleeding global report market
Global Prescription Drugs Market Analysis Report 2022: Increasing Number of Chronic Diseases Worldwide will Continue to Fuel Growth - Forecast to 2027
Published: 2023-01-19 (Crawled : 17:00) - prnewswire.com
TAK | $16.12 1.26% 0.0% 76
|
Health Technology
|
| O: 0.03%
H: 0.0%
C: 0.0%
NVO | $139.58 -0.01% 0.19% 1.9K
|
Health Technology
|
| O: 0.14%
H: 0.0%
C: 0.0%
NVS | $86.89 0.64% 0.0% 1K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
JNJ | $163.61 0.13% 0.29% 3.8K
|
Health Technology
|
| O: -1.45%
H: 0.0%
C: 0.0%
GSK | $36.32 0.42% 1.71% 20K
|
Health Technology
|
| O: 0.23%
H: 0.0%
C: 0.0%
LLY M | $340.73 0.31% 0.5% 970
|
Health Technology
|
| O: -1.35%
H: 0.0%
C: 0.0%
BMY S | $73.65 -1.17% 0.0% 410
|
Health Technology
|
| O: 0.19%
H: 0.0%
C: 0.0%
ABBV | $144.61 -0.37% 1.38% 150K
|
Health Technology
|
| O: -2.16%
H: 0.0%
C: 0.0%
SNY | $47.71 1.58% 1.57% 0
|
Health Technology
|
| O: -0.92%
H: 0.0%
C: 0.0%
GILD M | $85.67 -0.44% -0.42% 0
|
Health Technology
|
| O: 0.43%
H: 0.0%
C: 0.0%
AMGN | $240.2 -1.56% -1.57% 2K
|
Health Technology
|
| O: -0.9%
H: 0.0%
C: 0.0%
global report growth market
Worldwide Monoclonal Antibodies Industry to 2033 - Rising mAb Therapy Applications for Targeted Therapies Drives Growth
Published: 2023-01-18 (Crawled : 18:00) - prnewswire.com
VTRS | $11.92 -1.57% -1.59% 1.4K
|
Health Technology
|
| O: -0.17%
H: 0.25%
C: -2.96%
TMO | $579.23 -0.67% 0.35% 94
|
Health Technology
|
| O: 0.56%
H: 0.97%
C: -1.87%
NVO | $139.58 -0.01% 0.19% 1.9K
|
Health Technology
|
| O: 0.57%
H: 0.84%
C: -0.01%
NVS | $86.89 0.64% 0.0% 1K
|
Health Technology
|
| O: 0.08%
H: 0.01%
C: -1.16%
JNJ | $163.61 0.13% 0.29% 3.8K
|
Health Technology
|
| O: -1.47%
H: 0.0%
C: 0.0%
GSK | $36.32 0.42% 1.71% 20K
|
Health Technology
|
| O: -0.03%
H: 0.17%
C: -1.01%
LLY M | $340.73 0.31% 0.5% 970
|
Health Technology
|
| O: -1.13%
H: 0.0%
C: 0.0%
ABT | $110.2 -1.6% 0.0% 2.6K
|
Health Technology
|
| O: -0.16%
H: 0.33%
C: -1.5%
SNY | $47.71 1.58% 1.57% 0
|
Health Technology
|
| O: -0.14%
H: 0.0%
C: 0.0%
BIIB A | $285.45 -2.05% -2.05% 100
|
Health Technology
|
| O: 0.26%
H: 0.0%
C: 0.0%
AZN | $64.36 0.11% 5.44% 250K
|
Health Technology
|
| O: 1.36%
H: 0.33%
C: -1.13%
AMGN | $240.2 -1.56% -1.57% 2K
|
Health Technology
|
| O: 0.0%
H: 0.41%
C: -1.87%
for therapy growth
Novo Nordisk A/S – Share repurchase programme
Published: 2023-01-16 (Crawled : 15:00) - globenewswire.com
NVO | $139.58 -0.01% 0.19% 1.9K
|
Health Technology
| Email alert
Add to watchlist
repurchase
Novo Nordisk announces FDA approval of label update for Rybelsus® (semaglutide) allowing use as a first-line option for adults with type 2 diabetes
Published: 2023-01-13 (Crawled : 02:00) - prnewswire.com
NVO | $139.58 -0.01% 0.19% 1.9K
|
Health Technology
|
| O: 3.45%
H: 0.0%
C: 0.0%
rybelsus fda label for approval diabetes update
Global Drug Delivery Systems Market Size Projected to Reach $71.75 Billion By 2029
Published: 2023-01-12 (Crawled : 14:00) - prnewswire.com
JEWL | $1.7 1.8% -7.05% 530
|
n/a
|
| O: 11.62%
H: 1.92%
C: -12.33%
STSS | $1.39 -4.14% -4.69% 360
|
n/a
|
| O: 23.18%
H: 2.69%
C: -10.75%
TRUMF | $29.158 0.69% 0
|
Health Technology
|
| O: 1.14%
H: 1.49%
C: 0.07%
TRUMY | $28.84 -1.69% 12K
|
Manufacturing
|
| O: 1.42%
H: 0.0%
C: -0.65%
NVO | $139.58 -0.01% 0.19% 1.9K
|
Health Technology
|
| O: 0.22%
H: 0.0%
C: 0.0%
CAH | $79.92 1.67% 0.1% 26
|
Distribution Services
|
| O: -2.06%
H: 0.88%
C: 0.2%
BDX S | $250.23 -1.17% 0.0% 0
|
Health Technology
|
| O: 0.46%
H: 0.55%
C: -0.78%
drug global market
Novo Nordisk A/S - share repurchase programme
Published: 2023-01-09 (Crawled : 15:20) - globenewswire.com
NVO | $139.58 -0.01% 0.19% 1.9K
|
Health Technology
| Email alert
Add to watchlist
repurchase
Global Type 2 Diabetes Treatment Market Outlook Report 2022-2023 & 2027: Patent Cliff, Oral Antidiabetics, and Growing Focus on Accessibility and Affordability of Medicine Bolsters Growth
Published: 2023-01-04 (Crawled : 23:00) - prnewswire.com
NVS | $86.89 0.64% 0.0% 1K
|
Health Technology
|
| O: -0.84%
H: 0.0%
C: 0.0%
JNJ | $163.61 0.13% 0.29% 3.8K
|
Health Technology
|
| O: 0.22%
H: 0.0%
C: 0.0%
SNY | $47.71 1.58% 1.57% 0
|
Health Technology
|
| O: -3.07%
H: 0.0%
C: 0.0%
AZN | $64.36 0.11% 5.44% 250K
|
Health Technology
|
| O: -2.09%
H: 0.0%
C: 0.0%
treatment patent global report growing diabetes growth market
Gainers vs Losers
| 57% | 43% |
Top 10 Gainers
CZOO | $0.2001 -16.63% 1819.04% 12K
|
AVRO | $1.69 93.7% 49.57% 890K
|
Health Technology
WLDS | $0.6295 -2.05% 38.2% 14M
|
HPCO | $0.755 -6.05% 34.67% 3.7M
|
KPRX | $6.94 52.53% 27.66% 230K
|
Manufacturing
ICU | $4.8 3.67% 21.26% 740K
|
SOUN 4 | $4.63 28.61% 19.1% 3.2M
|
UUU | $2.07 -0.96% 17.87% 8
|
Electronic Technology
GENE | $1.46 -10.43% 14.66% 3.6M
|
Health Technology
MSGM P | $16.07 21.93% 13.23% 23K
|
Your saved searches
Save your searches and get alerts when important news are released.